Chemoinformaics analysis of 3-EPI-PERIPLOGENIN
| Molecular Weight | 390.52 | nRot | 1 |
| Heavy Atom Molecular Weight | 356.248 | nRig | 25 |
| Exact Molecular Weight | 390.241 | nRing | 5 |
| Solubility: LogS | -3.782 | nHRing | 1 |
| Solubility: LogP | 2.496 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 62 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 28 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 23 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 65.091 |
| nHD | 3 | BPOL | 36.713 |
| QED | 0.587 |
| Synth | 4.839 |
| Natural Product Likeliness | 2.404 |
| NR-PPAR-gamma | 0.385 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.011 |
| Pgp-sub | 0.077 |
| HIA | 0.462 |
| CACO-2 | -5.14 |
| MDCK | 0.0000205 |
| BBB | 0.886 |
| PPB | 0.95657 |
| VDSS | 1.308 |
| FU | 0.0452157 |
| CYP1A2-inh | 0.018 |
| CYP1A2-sub | 0.878 |
| CYP2c19-inh | 0.02 |
| CYP2c19-sub | 0.597 |
| CYP2c9-inh | 0.128 |
| CYP2c9-sub | 0.642 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.459 |
| CYP3a4-inh | 0.182 |
| CYP3a4-sub | 0.3 |
| CL | 18.137 |
| T12 | 0.096 |
| hERG | 0.083 |
| Ames | 0.024 |
| ROA | 0.985 |
| SkinSen | 0.357 |
| Carcinogencity | 0.415 |
| EI | 0.009 |
| Respiratory | 0.896 |
| NR-Aromatase | 0.811 |
| Antiviral | Yes |
| Prediction | 0.656785 |